The Government Is In A Tangle Over Selling Cannabis As A Medicine
Two government departments seem to disagree about whether cannabis products have a medicinal value.
Vendors of a product called cannabidiol, or CBD, an oil derived from cannabis plants, have received letters from the Medicines and Healthcare Products Regulatory Agency (MHRA), a Department of Health-sponsored agency, saying that they have to stop selling it in the next 28 days, because it has been designated as a medicine.
That means that they will probably have to undergo clinical trials, and demonstrate that they are safe and effective treatments for specific conditions, before they can be sold.
However, the Home Office considers cannabis a “schedule 1” drug, under the Misuse of Drugs Regulations 2001. That means that they consider it to have no therapeutic or medicinal value. It is possible to carry out medical research using schedule 1 drugs, but researchers must apply for special dispensation to do so, making it significantly harder to...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin